Dexloxiglumide (Standard)

Overview

Dexloxiglumide (Standard) is the analytical standard of Dexloxiglumide. This product is intended for research and analytical applications. Dexloxiglumide is an orally active and selective cholecystokinin type A ( CCKA ) receptor antagonist. Dexloxiglumide is the active enantiomer of Loxiglumide, inhibits smooth muscle cell contractions induced by cholecystokinin-octapeptide ( CCK-8 ). Dexloxiglumide exhibits moderate Caco-2 permeability that is polarized, concentration dependent, and pH dependent. Dexloxiglumide increases MRP1 -substrate fluorescein uptake. Dexloxiglumide can be studied in research for gastrointestinal diseases and tumors.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Others | Products > Research Areas > Metabolic Disease | Products > Research Areas > Endocrinology | Products > Signaling Pathways > Cholecystokinin Receptor | Products > Signaling Pathways > P-glycoprotein | Products > Signaling Pathways > Reference Standards

Product Information

• Catalog No.: HY-128878R
• CAS No.: 119817-90-2
• Molecular Formula: C21H30Cl2N2O5
• Molecular Weight: 461.38
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source